The U.S. Department of Justice on Thursday said it will not stand in the way of efforts by companies, including Eli Lilly and Co and Amgen Inc, to share information to help scale up capacity to manufacture antibody treatments for COVID-19, the disease caused …
U.S. clears way for drugmakers to share COVID antibody capacity – Reuters
Tweet on Twitter
Share on Facebook
Google+
Pinterest
